ReSuture Issued First Patent

It is with immense gratitude and satisfaction that ReSuture is announcing the issuance of our first patent (US11904508B2)! What started as experimentation in a small lab in the back of a medical school to create more realistic training for surgeons has transformed into a patented process that allows ReSuture to make pathology-specific vasculature for surgical training. After five years of dedication and hard work, this achievement marks a significant leap forward for our team.

This patent is a testament to our commitment to innovation and excellence in the field of surgical simulation. It safeguards ReSuture’s unique manufacturing method, and particularly how we build disease conditions into our models. This critical aspect sets us apart and gives ReSuture a key competitive advantage in the industry. We are so excited about ReSuture’s future, and are sure this is just the first of many patent announcements to come! If you’d like to learn more about ReSuture’s current R&D as we continue to push the boundaries of surgical device training